BCL2 and acute lymphoblastic leukemia: [21] reported that sertraline reduced viability in T‐cell acute lymphoblastic leukemia cells, accompanied by findings consistent with TCTP inhibition, namely TCTP destabilization, Bcl‐2 downregulation, and activation of caspase‐3.